ArticleInternational journal of women's dermatology2021
Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018.
Article in International journal of women's dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Academic productivity correlates with industry earnings in foot and ankle fellowship programs in the United States: A retrospective analysis.World journal of orthopedics · 2024Article
- Evaluating the Correlation Between Various Orthopaedic Foot and Ankle Fellowship Characteristics and Total Industry Payments Through the Open Payments Database.Foot & ankle orthopaedics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmaceutical payments may affect the interpretation of clinical research and prescribing patterns of physicians. Additionally, they may reflect gender disparities in academic dermatology with regard to social recognition and opportunities for career advancement.
objectiveWe examined relationships with industry among male and female journal editors who accepted pharmaceutical payments in leading dermatology journals.
methodsWe assessed the seven US journals among the leading 20 dermatology journals as determined by impact factor and gathered data via the CMS Open Payments dataset.
resultsIn a cross-sectional study of 329 editors eligible to appear in the Open Payments website, we found that 218 (66.3%) received industry payments totaling $21,952,402. The mean and median dollar value of payments per editor was $100,699 and $3,638 (interquartile range, $364-$57,108). Food and beverage payments accounted for 63.0% of the $28,992 total payments, and the associated dollar value was $887,617 (4.04%). Gender disparities in corporate payments were observed in other contexts, but we did not find a similar relationship among leading dermatology journals.
conclusionOur work highlights that pharmaceutical payments exist among dermatology editors, providing a rationale for future research to address whether editor bias related to pharmaceutical payments exists and more granular studies on the role of gender with regard to navigating such payments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.